About us

The Finnish Medicines Agency Fimea is the national competent authority for regulating pharmaceuticals. As a central administrative agency operating under the Ministry of Social Affairs and Health it promotes the health and safety of the population by regulating medicinal, medical devices, blood and tissue products, biobanks and by developing the pharmaceuticals sector.

 

Subscribe to Fimea Newsletter 

 

Asset Publisher

Meds75+ database arouses international interest

Meds75+ database arouses international interest 18.11.2024 The Meds75+ database maintained by Fimea and the utilisation of the data content have also aroused...

Fimea has defined further measures for non-transferred clinical trials

Fimea has defined further measures for non-transferred clinical trials 30.9.2024 | Published in English on 2.10.2024 at 16.39 According to Directive...

Prices of clinical trials to be lowered in special cases

Prices of clinical trials to be lowered in special cases 20.9.2024 | Published in English on 2.10.2024 at 15.22 Fimea and Tukija have made a decision on the...

Open data addresses to change at the end of September

Open data addresses to change at the end of September 20.9.2024 | Published in English on 24.9.2024 at 9.36 Fimea is transferring open data files to a new...

Fimea published its sustainability report for 2023, aims for a sustainable future

Fimea published its sustainability report for 2023, aims for a sustainable future 30.4.2024 | Published in English on 28.6.2024 at 13.17 The Finnish...

About us sininen

About Fimea

Fimea’s aim is to improve the pharmaceutical service for the population and the safety, appropriateness and economy of pharmacotherapy. Fimea also enchances and provides the general population and other interested parties with impartial information on medicinal products.

Fimea will work in a close cooperation with relevant parties and stakeholders in the pharmaceutical field. Fimea will also strengthen its collaboration with the European Medicines Agency (EMA) with regard to the regulatory processes of medicinal products in the EU, and will further expand its international cooperation.

Organisation

Fimea's operations are divided into four areas of responsibility, under which the operating entities are grouped: Marketing authorisations, Safety and effectiveness, Supervision and availability and Joint services. In addition, Development and Information Services and Communications Services operate directly under the director general.

Fimea's headquarters are in Kuopio. Fimea also has offices in Helsinki, Turku, Tampere and Oulu.

Fimea’s Year 2021

The website: Year 2021

Responsibility at Fimea – Responsibility report 2021

About us: etusivu lomakelista